About this trial
This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).
Eligibility criteria
Qualifiers
Positive diagnosis (anatomopathology) of tumor within 12 months
Patient 18 years of age or older
Desmoid fibromatosis of the abdominal wall operated on or under active surveillance
Stage I testicular seminoma (whether or not treated with carboplatin AUC7)
Disqualifiers
Contraindication to imaging tests required for the surveillance plan
No telephone
Patient under guardianship or curatorship
Trial design
Treatments tested in this trial
- Oncological Follow-up
Treatment groups
Sponsors and collaborators
Centre Oscar Lambret
Lead sponsor
Canceropôle Nord Ouest
Collaborator
Groupement Interrégional de Recherche Clinique et d'Innovation
Collaborator